Literature DB >> 32575497

Trends, Coverage and Influencing Determinants of Influenza Vaccination in the Elderly: A Population-Based National Survey in Spain (2006-2017).

Silvia Portero de la Cruz1, Jesús Cebrino2.   

Abstract

Influenza is a significant public health problem and the elderly are at a greater risk of contracting the disease. The vaccination coverage of the elderly is below the Spanish target of 65% for each influenza season. The aims of this study were to report the coverage of influenza vaccination in Spain among the population aged ≥65 years and high-risk groups for suffering chronic diseases, to analyze the time trends from 2006 to 2017 and to identify the factors which affect vaccination coverage. A nationwide cross-sectional study was conducted including 20,753 non-institutionalized individuals aged ≥65 years who had participated in the Spanish National Health Surveys in 2006, 2011/2012, and 2017. Sociodemographic, health-related variables, and influenza vaccination data were used. A logistic regression analysis was performed to determine the variables associated with influenza vaccination. Influenza vaccination coverage was 60%. By chronic condition, older people with high cholesterol levels and cancer had the lowest vaccination coverage (62.41% and 60.73%, respectively). This coverage declined from 2006 to 2017 in both groups. Higher influenza vaccination was associated with males, Spanish nationality, normal social support perceived, polypharmacy, worse perceived health, participation in other preventive measures, and increasing age and the number of chronic diseases.

Entities:  

Keywords:  aged; human; influenza; influenza vaccines; trends; vaccination coverage

Year:  2020        PMID: 32575497     DOI: 10.3390/vaccines8020327

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  6 in total

1.  Factors associated with COVID-19 vaccination behaviour in Latvian population: cross-sectional study.

Authors:  Sanita Šuriņa; Kristīne Mārtinsone; Gatis Upesleja; Viktorija Perepjolkina
Journal:  Health Psychol Behav Med       Date:  2022-06-07

2.  Predictors of Influenza Vaccination Uptake and the Role of Health Literacy among Health and Social Care Volunteers in the Province of Prato (Italy).

Authors:  Chiara Lorini; Vieri Lastrucci; Beatrice Zanella; Eleonora Gori; Fabrizio Chiesi; Angela Bechini; Sara Boccalini; Marco Del Riccio; Andrea Moscadelli; Francesco Puggelli; Renzo Berti; Paolo Bonanni; Guglielmo Bonaccorsi
Journal:  Int J Environ Res Public Health       Date:  2022-05-30       Impact factor: 4.614

3.  The association between the density of vaccination workers and immunization coverage in Zhejiang province, East China.

Authors:  Yu Hu; Yaping Chen; Ying Wang; Hu Liang; Huakun Lv
Journal:  Hum Vaccin Immunother       Date:  2021-02-05       Impact factor: 3.452

4.  Low Levels of Influenza Vaccine Uptake among the Diabetic Population in Spain: A Time Trend Study from 2011 to 2020.

Authors:  Jose J Zamorano-Leon; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Javier de-Miguel-Diez; David Carabantes-Alarcon; Romana Albaladejo-Vicente; Rosa Villanueva-Orbaiz; Khaoula Zekri-Nechar; Sara Sanz-Rojo
Journal:  J Clin Med       Date:  2021-12-23       Impact factor: 4.241

5.  Time Trends (2012-2020), Sex Differences and Predictors for Influenza Vaccination Uptake among Individuals with Chronic Obstructive Pulmonary Disease in Spain.

Authors:  Marta Fuentes-Alonso; Rodrigo Jimenez-Garcia; Ana Lopez-de-Andres; Jose J Zamorano-Leon; David Carabantes-Alarcon; Isabel Jimenez-Trujillo; Sara Sanz-Rojo; Javier de Miguel-Diez
Journal:  J Clin Med       Date:  2022-03-04       Impact factor: 4.964

6.  Knowledge, attitudes, beliefs and barriers of healthcare professionals and adults ≥ 65 years about vaccine-preventable diseases in Spain: the ADult Vaccination drIverS and barriErs (ADVISE) study.

Authors:  Esther Redondo Margüello; Antoni Trilla; Ignacio L B Munguira; Almudena Jaramillo López-Herce; Manuel Cotarelo Suárez
Journal:  Hum Vaccin Immunother       Date:  2022-02-16       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.